National Trends in Child and Adolescent Psychotropic Polypharmacy in Office-Based Practice, 1996-2007
- 2 September 2010
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 49 (10), 1001-1010
- https://doi.org/10.1016/j.jaac.2010.07.007
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and AdolescentsJAMA, 2009
- Effectiveness of Lamotrigine in Maintaining Symptom Control in Pediatric Bipolar DisorderJournal of Child and Adolescent Psychopharmacology, 2009
- Cognitive Behavioral Therapy, Sertraline, or a Combination in Childhood AnxietyNew England Journal of Medicine, 2008
- A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorderChild and Adolescent Psychiatry and Mental Health, 2007
- Psychotropic Medication Utilization in a Child and Adolescent Mental Health ServiceJournal of Child and Adolescent Psychopharmacology, 2006
- Adjunctive olanzapine treatment in bipolar adolescents responding insufficiently to mood stabilizersEuropean Child & Adolescent Psychiatry, 2006
- Concomitant Pharmacotherapy among Youths Treated in Routine Psychiatric PracticeJournal of Child and Adolescent Psychopharmacology, 2005
- The Effect of Atypical Antipsychotic Agents on Prolactin Levels in Children and AdolescentsJournal of Child and Adolescent Psychopharmacology, 2004
- Concomitant Psychotropic Medication for YouthsAmerican Journal of Psychiatry, 2003
- Changing Patterns of Psychotropic Medications Prescribed by Child Psychiatrists in the 1990sJournal of Child and Adolescent Psychopharmacology, 1997